Beauty Farm issues positive profit alert: 1H 2026 revenue projected at ≥RMB1.88 billion, net profit up at least 37%

Bulletin Express07-20

Beauty Farm Medical and Health Industry Inc. (Beauty Farm) announced a positive profit alert for the six months ended 30 June 2026, indicating substantial top-line and bottom-line growth driven by its “internal growth + external acquisitions” strategy.

Revenue and Earnings • Revenue is expected to exceed RMB1.88 billion, representing growth of no less than 28% year-on-year. • Net profit is projected at a minimum of RMB235 million, up at least 37% from the prior-year period. • Adjusted net profit—excluding share-based compensation, amortisation of acquisition-related intangibles and one-off costs—is anticipated to reach at least RMB260 million, an increase of no less than 36% year-on-year.

Operational Drivers 1. External acquisitions: – The January 2026 consolidation of Siyanli, China’s third-ranked beauty service brand, expanded Beauty Farm’s footprint across premium locations in 20 core cities. – Synergy realisation from both the 2024 acquisition of Naturade and the newly integrated Siyanli contributed to incremental revenue and profitability during the Reporting Period.

2. Internal growth and efficiency: – Same-store sales continued to rise at directly operated outlets, supported by brand upgrades and refined digital operations. – In consumer healthcare, the CellCare aesthetic medical brand introduced expert-driven anti-aging solutions, bolstering service volume and average transaction values. – Ongoing platform efficiencies and economies of scale improved organic profit margins.

Capital-Market Actions Regular share repurchases and a maintained high-dividend policy were highlighted as measures to enhance per-share earnings and reinforce the company’s valuation appeal.

Outlook Management reiterated confidence in achieving full-year growth targets, asserting that the dual-engine strategy and “dual beauty + dual wellness” model will continue to underpin performance momentum.

The interim results for 1H 2026 are still being finalised; figures cited above are based on the Board’s preliminary assessment of unaudited management accounts. Final numbers are scheduled for release by end-August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment